Evidence map›Paper›PMID 20161797›Full record

ArticlePloS one2010

Potent anti-inflammatory activity of novel microtubule-modulating brominated noscapine analogs.

Susu Zughaier, Prasanthi Karna, David Stephens, Ritu Aneja

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Noscapine, an Emerging Medication for Different Diseases: A Mechanistic Review.Evidence-based complementary and alternative medicine : eCAM · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Ibuprofen regulation of microtubule dynamics in cystic fibrosis epithelial cells.American journal of physiology. Lung cellular and molecular physiology · 2016
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. The role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes.Journal of clinical & translational endocrinology · 2014
    Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Susu ZughaierDivision of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, United States of America. szughai@emory.edu
Prasanthi Karna
David Stephens
Ritu Aneja
Emory University · USGeorgia State University · US

Funding

MENINGOCOCCAL LIPOOLIGOSACCHARIDE &MUCOSAL PATHOGENESISR01AI033517 · NIAID · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 1993 to 2007
$1.7M
Evaluation of antiangiogenic role of EM011, a novel tubulin-binding agentR00CA131489 · NCI · GEORGIA STATE UNIVERSITY · PI ANEJA, RITU · 2010 to 2012
$732k
Evaluation of antiangiogenic role of EM011, a novel tubulin-binding agentK99CA131489 · NCI · GEORGIA STATE UNIVERSITY · PI ANEJA, RITU · 2008 to 2009
$318k
NCI NIH HHS K99 CA131489NCI NIH HHS PC073104NCI NIH HHS R00 CA131489NIAID NIH HHS R01 AI033517
6 · The paper itself

Abstract

Noscapine, a plant-derived, non-toxic, over-the-counter antitussive alkaloid has tubulin-binding properties. Based upon the structural resemblance of noscapine to colchicine, a tubulin-binding anti-inflammatory drug, noscapine and its semi-synthetic brominated analogs were examined for in vitro anti-inflammatory activity. Brominated noscapine analogs were found to inhibit cytokine and chemokine release from macrophage cell lines but did not affect cell viability. Brominated noscapine analogs demonstrated anti-inflammatory properties in both TLR- and non-TLR induced in vitro innate immune pathway inflammation models, mimicking septic and sterile infection respectively. In addition, electron microscopy and immunoblotting data indicated that these analogs induced robust autophagy in human macrophages. This study is the first report to identify brominated noscapines as innate immune pathway anti-inflammatory molecules.

Indexed as

AnimalsAnti-Inflammatory AgentsAntitussive AgentsAutophagyBlotting, WesternCell LineChemokine CXCL10Dose-Response Relationship, DrugHalogenationHumansInterleukin-8MacrophagesMicroscopy, ElectronModels, BiologicalMolecular StructureNitric OxideAnti-Inflammatory AgentsAntitussive AgentsChemokine CXCL10Interleukin-8Nitric OxideNoscapineReactive Oxygen SpeciesToll-Like Receptor 4Tubulin ModulatorsTumor Necrosis Factor-alpha

Identifiers

PMID20161797
PMCPMC2820095
OpenAlexW2003219556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.